PTEN Protein Loss by IHC Is an Adverse Prognostic Indicator in a High Risk Surgical Cohort of Prostate Cancer Patients

被引：0
|
作者：
Lotan, T. L. [1 ]
Suteliffe, S. [1 ]
Gurel, B. [1 ]
Park, B. H. [1 ]
Humphries, E. [1 ]
Partin, A. W. [1 ]
Han, M. [1 ]
Walsh, P. C. [1 ]
De Marzo, A. M. [1 ]
机构：
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
909
引用
收藏
页码：205A / 205A
页数：1
相关论文
共 50 条
  • [1] PTEN Protein Loss by IHC Is an Adverse Prognostic Indicator in a High Risk Surgical Cohort of Prostate Cancer Patients
    Lotan, T. L.
    Sutcliffe, S.
    Gurel, B.
    Park, B. H.
    Humphries, E.
    Partin, A. W.
    Han, M.
    Walsh, P. C.
    De Marzo, A. M.
    LABORATORY INVESTIGATION, 2010, 90 : 205A - 205A
  • [2] PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
    Lotan, Tamara L.
    Gurel, Bora
    Sutcliffe, Siobhan
    Esopi, David
    Liu, Wennuan
    Xu, Jianfeng
    Hicks, Jessica L.
    Park, Ben H.
    Humphreys, Elizabeth
    Partin, Alan W.
    Han, Misop
    Netto, George J.
    Isaacs, William B.
    De Marzo, Angelo M.
    CLINICAL CANCER RESEARCH, 2011, 17 (20) : 6563 - 6573
  • [3] Determination of Intratumoral Heterogeneity for PTEN Loss in Prostate Cancer by IHC for PTEN and ERG
    Ocal, B. Gumuskaya
    Gurel, B.
    Hicks, J. L.
    Lotan, T.
    De Marzo, A. M.
    LABORATORY INVESTIGATION, 2012, 92 : 210A - 210A
  • [4] Determination of Intratumoral Heterogeneity for PTEN Loss in Prostate Cancer by IHC for PTEN and ERG
    Ocal, B. Gumuskaya
    Gurel, B.
    Hicks, J. L.
    Lotan, T.
    De Marzo, A. M.
    MODERN PATHOLOGY, 2012, 25 : 210A - 210A
  • [5] PTEN Loss in a Prostate Cancer Cohort From Jordan
    Al Bashir, Samir
    Alzoubi, Abdallah
    Alfaqih, Mahmoud A.
    Kheirallah, Khalid
    Smairat, Aya
    Haddad, Husam
    Al-Dwairy, Ahmad
    Fawwaz, Baha A. B.
    Alzoubi, Mazhar
    Trpkov, Kiril
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (05) : 389 - 394
  • [6] A genomic classifier independently prognostic of prostate cancer death in a high-risk surgical cohort
    Cooperberg, Matthew R.
    Crisan, Anamaria
    Mitra, Anirban Pradip
    Ghadessi, Mercedeh
    Buerki, Christine
    Davicioni, Elai
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [7] PTEN Loss but Not ERG Expression in Diagnostic Biopsies Is Associated with Increased Risk of Progression and Adverse Surgical Findings in Men with Prostate Cancer on Active Surveillance
    Lokman, Utku
    Erickson, Andrew M.
    Vasarainen, Hanna
    Rannikko, Antti S.
    Mirtti, Tuomas
    EUROPEAN UROLOGY FOCUS, 2018, 4 (06): : 867 - 873
  • [8] Blood lactate: an excellent prognostic indicator in high-risk surgical patients
    AF Meregalli
    UL Sant'Anna
    ES Oliveira
    G Friedman
    Critical Care, 3 (Suppl 1):
  • [9] Prevalence of ERG expression and PTEN loss in a Brazilian prostate cancer cohort
    Morais, C. E.
    Gurgel, D. C.
    Teixeira, A. C.
    Arruda Mattos, T., V
    Alves da Silva, A., V
    Tavora, F.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2019, 52 (12)
  • [10] PTEN Status Determination in Prostate Cancer: Comparison of IHC and FISH in a Large Multi-Center Cohort
    Lotan, Tamara
    Moray, Carlos
    Wei, Wei
    Troyer, Dean
    Jamaspishvili, Tamara
    McKenney, Jesse
    Simko, Jeff
    Brooks, James
    Squire, Jeremy
    LABORATORY INVESTIGATION, 2015, 95 : 241A - 241A
12345